drugset / Trial / NCT00901914
Study of rBet v1 Tablets
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of three doses of r Bet v1 administered as sublingual tablets in birch pollen allergic subjects.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-06
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rBet v 1 | Protein / enzyme biologic | 12.5 ug | Other |
| Subject | rBet v 1 | Protein / enzyme biologic | 25 ug | Other |
| Subject | rBet v 1 | Protein / enzyme biologic | 50 ug | Other |